Insider Shareholders with Direct Ownership of Chimerix Inc (CMRX)
This section provides a comprehensive overview of the insiders with direct ownership of Chimerix Inc (CMRX). You can find detailed information about the size and nature of each insider's ownership stake, as well as the latest updates on their holdings.
CHIMERIX INC Insider List
| Insider | Adquired | Disposed | Held | # of Trades | Last Transaction |
|---|---|---|---|---|---|
|
Cantex Pharmaceuticals, Inc.
> 10% Shareholder |
0 | 6,500,000 | 3,500,000 $11.7 Million | 1 |
Sep 14, 2021
Reduced 65.0%
|
|
Michael T. Andriole
PRESIDENT AND CEO |
257,625 | 20,029 | 462,453 $1.54 Million | 9 |
Aug 08, 2024
Reduced 0.28%
|
|
Michael A. Sherman
Chief Executive Officer |
192,950 | 0 | 222,995 $744,803 | 2 |
Jan 17, 2023
Added 29.42%
|
| 10,000 | 0 | 207,523 $693,126 | 2 |
Jun 28, 2021
Added 3.24%
|
|
|
Michael Albert Alrutz
SVP AND GENERAL COUNSEL |
43,325 | 0 | 168,098 $561,447 | 2 |
Feb 01, 2024
Added 11.51%
|
|
David Jakeman
VP OF FINANCE AND ACCOUNTING |
58,350 | 30,555 | 141,232 $471,714 | 14 |
Feb 14, 2024
Reduced 1.85%
|
|
Michelle La Spaluto
CHIEF FINANCIAL OFFICER |
25,000 | 1,940 | 110,999 $370,736 | 2 |
Feb 14, 2024
Reduced 1.72%
|
|
Allen S. Melemed
CHIEF MEDICAL OFFICER |
53,865 | 0 | 86,430 $288,676 | 2 |
Feb 01, 2024
Added 24.55%
|
| 21,650 | 0 | 35,150 $117,401 | 3 |
May 08, 2023
Added 19.93%
|
|
| 7,042 | 7,042 | 0 $0 | 2 |
Nov 17, 2020
Reduced 100.0%
|